4.5 Article

Polyphenol mixtures of Euphorbia supina the inhibit invasion and metastasis of highly metastatic breast cancer MDA-MB-231 cells

Journal

ONCOLOGY REPORTS
Volume 34, Issue 6, Pages 3035-3042

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/or.2015.4304

Keywords

breast cancer cells; endothelial cells; metastasis; Euphorbia supina; VCAM-1; epithelial-mesenchymal transition

Categories

Funding

  1. National R&D Program for Cancer Control, the Ministry of Health and Welfare, Republic of Korea [0820050]
  2. Korea Health Promotion Institute [0820050] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

The Korean prostrate spurge Euphorbia supina is abundant in polyphenols and has been used as a folk medicine in Korea against a variety of diseases. Thus, we aimed to investigate the effect of polyphenol mixtures of Korean Euphorbia supina (PES) on the invasion and metastasis of highly metastatic breast cancer MDA-MB-231 cells. Firstly, PES showed no cytotoxicity on cancer cells and endothelial cells (ECs) at the doses of 0.1-10 mu g/ml, but showed significant cytotoxicity from 50 mu g/ml. Thus, we performed subsequent experiments with PBS at doses up to 5 mu g/ml. PES dose-dependently suppressed epithelial-mesenchymal transition by downregulating the mesenchymal markers, Snaill and N-cadherin, showing significant inhibition from 1 and 5 mu g/ml, respectively. In addition, PES significantly inhibited MMP-9 activity and LOX release induced by TNF-alpha at 5 mu g/ml. Then, we determined the effect of PBS on the expression of adhesion molecules and VE-cadherin phosphorylation. The results showed that PES effectively reduced TNF-alpha-mediated VCAM-1 expression but not ICAM expression both in the MDA-MB-231 cells and ECs, resulting in the reduced adhesion of MDA-MB-231 to ECs. Finally, PES effectively inhibited MDA-MB-231 cell invasion through ECs, suggesting that PBS may serve as a therapeutic agent against cancer metastasis with minimal cytotoxicity to normal cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available